These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2714131)

  • 1. 5-Aminosalicylic acid suppositories in the management of ulcerative colitis.
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Torresan F; Tampieri M; Iannone P; Miglioli M; Barbara L
    Dis Colon Rectum; 1989 May; 32(5):398-9. PubMed ID: 2714131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: a double-blind placebo-controlled clinical trial.
    D'Arienzo A; Panarese A; D'Armiento FP; Lancia C; Quattrone P; Giannattasio F; Boscaino A; Mazzacca G
    Am J Gastroenterol; 1990 Sep; 85(9):1079-82. PubMed ID: 2202199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation. A double-blind placebo controlled trial.
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Brunetti G; Miglioli M; Barbara L
    Int J Colorectal Dis; 1990 May; 5(2):79-81. PubMed ID: 2193075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis?
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tabanelli GM; Miglioli M; Barbara L
    J Clin Gastroenterol; 1988 Aug; 10(4):406-9. PubMed ID: 3418088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis.
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Miglioli M; Barbara L
    Gut; 1991 Aug; 32(8):929-31. PubMed ID: 1885075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA].
    Jo Y; Matsumoto T; Iida M
    Nihon Rinsho; 2005 May; 63(5):820-4. PubMed ID: 15881176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K; Fischer C; Klotz U; Heinkel K
    Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1131-4. PubMed ID: 6123426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage].
    Bresci G; Carrai M; Venturini G; Gambardella L
    Minerva Dietol Gastroenterol; 1990; 36(1):31-3. PubMed ID: 1970855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results.
    Guarino J; Chatzinoff M; Berk T; Friedman LS
    Am J Gastroenterol; 1987 Aug; 82(8):732-7. PubMed ID: 3496786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic efficacy of 5-ASA molecules in idiopathic intestinal inflammatory diseases: critical review].
    Van Gossum A
    Acta Gastroenterol Belg; 1992; 55(5-6):462-71. PubMed ID: 1363167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent versus continuous 5-aminosalicylic acid treatment for maintaining remission in ulcerative colitis.
    Bardazzi G; d'Albasio G; Bonanomi AG; Trallori G; Messori A; Amorosi A; Bartoletti L; Morettini A; Pacini F
    Ital J Gastroenterol; 1994 Sep; 26(7):334-7. PubMed ID: 7812025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-ASA enemas for refractory distal ulcerative colitis. An open trial.
    Kandel G; Prokipchuk EJ
    J Clin Gastroenterol; 1987 Oct; 9(5):536-40. PubMed ID: 3680902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW; Gales BJ
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study.
    Ardizzone S; Petrillo M; Molteni P; Desideri S; Bianchi Porro G
    J Clin Gastroenterol; 1995 Dec; 21(4):287-9. PubMed ID: 8583101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practicality of 5-aminosalicylic suppositories for long-term treatment of inactive distal ulcerative colitis.
    Casellas F; Vaquero E; Armengol JR; Malagelada JR
    Hepatogastroenterology; 1999; 46(28):2343-6. PubMed ID: 10521994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM; Greenberg GR
    Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukopenia and thrombocytopenia as adverse effects of treatment with 5-aminosalicylic suppositories.
    Casellas F; Vallano A; Malagelada JR
    J Clin Gastroenterol; 1996 Mar; 22(2):160-1. PubMed ID: 8742664
    [No Abstract]   [Full Text] [Related]  

  • 19. Once daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis.
    Li W; Zhang ZM; Jiang XL
    Colorectal Dis; 2016 Jul; 18(7):O214-23. PubMed ID: 27214762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis.
    Mantzaris GJ; Hatzis A; Petraki K; Spiliadi C; Triantaphyllou G
    Dis Colon Rectum; 1994 Jan; 37(1):58-62. PubMed ID: 8287749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.